2.A case of transcaval transcatheter aortic valve replacement.
Zhen Gang ZHAO ; Zhong Kai ZHU ; Yong PENG ; Jia Fu WEI ; Sen HE ; Yong CHEN ; Xuan ZHOU ; Xin WEI ; Ming Xia ZHENG ; Guo CHEN ; Wei MENG ; Bin HUANG ; Yuan FENG ; Mao CHEN
Chinese Journal of Cardiology 2022;50(3):292-294
3.Triple cusps replacement for active aortic endocarditis.
Chao WANG ; Qi MIAO ; Chao-Ji ZHANG ; Xing-Rong LIU ; Guo-Tao MA ; Jian-Zhou LIU ; Xiao-Feng LI ; Hai-Bo DENG
Chinese Medical Journal 2013;126(7):1400-1400
Aortic Valve
;
surgery
;
Endocarditis
;
surgery
;
Humans
6.Transcatheter Aortic Valve Implantation in a Patient with Previous Mitral Valve Replacement.
Sung Woo MOON ; Young Guk KO ; Geu Ru HONG ; Sak LEE ; Byung Chul CHANG ; Jae Kwang SHIM ; Young Ran KWAK ; Myeong Ki HONG
Korean Circulation Journal 2014;44(5):344-347
Transcatheter aortic valve implantation (TAVI) has shown favorable outcomes in patients with severe symptomatic aortic valve stenosis who are at high surgical risk or are unsuitable candidates for open heart surgery. However, concerns exist over treating patients who have previously undergone mitral valve surgery due to the potential interference between the mitral prosthetic valve or ring and the TAVI device. In this case report, we present a patient with symptomatic severe aortic stenosis and previous mechanical mitral valve replacement who was successfully treated with TAVI using a CoreValve.
Aortic Valve Stenosis
;
Aortic Valve*
;
Catheters
;
Heart Valve Prosthesis
;
Humans
;
Mitral Valve*
;
Prosthesis Implantation
;
Thoracic Surgery
8.Midterm outcome comparison between patients with bicuspid or tricuspid aortic stenosis undergoing transcatheter aortic valve replacement.
Jie LI ; Ying Hao SUN ; Guang LI ; Ming FU ; Yu Jing MO ; Sheng Neng ZHENG ; Hao Jian DONG ; Rui Xin FAN ; Jian Fang LUO
Chinese Journal of Cardiology 2020;48(9):759-764
Objective: To compare the prognosis of transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BAV) or tricuspid aortic valve (TAV) stenosis. Methods: This was a retrospective study. Patients with symptomatic severe aortic stenosis, who underwent TAVR with follow-up time more than one year in Guangdong Provincial People's Hospital from April 2016 to August 2018, were included. According to aortic CT angiography, the patients were divided into BAV group and TAV group. The primary endpoint was the composite event of all-cause death and stroke, and the secondary endpoints were TAVR-related complications. Incidence of clinical endpoints and parameters derived from echocardiography were compared between the groups, and Kaplan-Meier survival analysis was used to compare the composite event between the two groups. Results: A total of 49 patients were included. The age was (73.6±6.3) years, and 25(51.0%) were male. There were 32 patients in BAV group and 17 in TAV group, the follow-up time was 466 (390, 664) days. The incidence of composite endpoint of death and stroke at one year were comparable in BAV and TAV groups (6.3% (2/32) vs. 5.9% (1/17), P=1.00). Kaplan-Meier curves also showed a similar risk of the composite endpoint(HR=1.03，95%CI 0.09-11.24，Log-rank P=0.98) between two groups. The incidence of all-cause death, stroke, myocardial infarction, severe bleeding, major vascular complications, new-onset atrial fibrillation or atrial flutter, and permanent pacemaker implantation were all similar between the two groups(all P>0.05), and there was no acute kidney injury (stage 2 or 3) in both groups. Echocardiographic parameters at one year were similar between the two groups (all P>0.05). Conclusions: The midterm prognosis of TAVR in patients with BAV and TAV stenosis is similar. Clinical trials of large sample size with long-term follow-up are warranted to verify our findings.
Aortic Valve/surgery*
;
Aortic Valve Stenosis/surgery*
;
Heart Valve Diseases
;
Humans
;
Male
;
Retrospective Studies
;
Transcatheter Aortic Valve Replacement
;
Treatment Outcome
Result Analysis
Print
Save
E-mail